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Abstract: Complete restoring of functional connectivity between neurons or target tissue after
traumatic lesions is still an unmet medical need. Using models of nerve axotomy and compression,
we investigated the effect of autophagy induction by genetic and pharmacological manipulation on
motor nerve regeneration. ATG5 or NAD+-dependent deacetylase sirtuin-1 (SIRT1) overexpression
on spinal motoneurons stimulates mTOR-independent autophagy and facilitates a growth-competent
state improving motor axonal regeneration with better electromyographic records after nerve
transection and suture. In agreement with this, using organotypic spinal cord cultures and the
human cell line SH-SY5Y, we observed that the activation of SIRT1 and autophagy by NeuroHeal
increased neurite outgrowth and length extension and that this was mediated by downstream
HIF1a. To conclude, SIRT1/Hifα-dependent autophagy confers a more pro-regenerative phenotype to
motoneurons after peripheral nerve injury. Altogether, we provide evidence showing that autophagy
induction by SIRT1/Hifα activation or NeuroHeal treatment is a novel therapeutic option for improving
motor nerve regeneration and functional recovery after injury.
Keywords: peripheral nerve injury; axonal regeneration; motoneuron; autophagy;
SIRT1/Hif1α; NeuroHeal
1. Introduction
Peripheral nerve injury (PNI) is caused by traffic accidents, lesions at home, or at the workplace,
which may result in a partial or total loss of motor function or sensory perception [1]. PNI directly
affects about approximately 13–23 people per 100,000 per year, aged 20–40 years, resulting in an
important economic cost in the healthcare of developed countries, mostly due to sick leave and the
consequent loss of production [2–4]. Surgical repair, decompression, lysis, and functional exercise are
important in recovering the function of a peripheral nerve promoting regeneration and maintaining
muscle mass [5]. Nevertheless, functional recovery is often not satisfactory despite the intrinsic
capability for regeneration of injured axons or reinnervation by collateral branching of undamaged
axons in the vicinity of the target [1]. Currently, at clinics, there is no coadjuvant treatment in use to
promote nerve regeneration. For this purpose, our group has recently proposed a promising compound
named NeuroHeal [6,7]. It was designed using a network-centric approach and artificial intelligence
and proved to be neuroprotective and accelerate nerve regeneration in several rodent models of
axotomy [6,7]. NeuroHeal is formed by a combination of two FDA-approved drugs: acamprosate and
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ribavirin. One of the key nodes of the synergic mechanism of action of NeuroHeal in neuroprotection is
the NAD+-dependent deacetylase sirtuin-1 (SIRT1), a widely described sensor of cellular stress [8–10].
However, the underlying mechanisms involved in nerve regeneration are not known yet.
We have recently demonstrated that NeuroHeal induces fine-tuned pro-survival macroautophagy
(hereafter, termed autophagy) to neuroprotect axotomized neonatal motoneurons from apoptosis
[manuscript in revision]. [11]. Autophagy is a catabolic process essential for sustaining the living
and homeostasis of the cells, characterized by the presence of de-novo formed autophagic vesicles
(autophagosomes) with superfluous or potentially dangerous cytoplasmic material that is delivered to
lysosomes for degradation [11]. It can be triggered by several different stimuli, including the activation
of SIRT1 [12]. Because of their polarized morphology, neurons face special challenges when recycling
cellular components through autophagy in dendrites and distal regions of axons. The canonical
formation of the autophagosome involves different steps including induction, autophagosome
formation, the fusion of the autophagosome with the lysosome, and cargo degradation, followed
by the release of breakdown products into the cytosol. Autophagy involves a group of highly
conserved genes, first found in yeast, termed autophagy-related genes (ATGs). In cells undergoing
autophagy, phagophore formation initiates after the Unc-51 like autophagy activating kinase 1 (ULK1)
activation, and its elongation is regulated by two ubiquitin-like reactions: the first leading to the
formation of the complex ATG12-ATG5-ATG16L1; and the second involving the conjugation of the
microtubule-associated protein light chain 3 (MAP-LC3/ATG8/LC3) to phosphatidylethanolamine (PE)
at the autophagosome membrane to form autophagosome-associated LC3-II. Once the autophagosome
is formed, it acquires the ability to bind autophagic substrates and/or proteins that mediate cargo
selectivity (including p62). Autophagosomes mobilize toward lysosomes along microtubules; then,
the outer membrane of the autophagosome fuses with the lysosome to form an autolysosome. Proper
function and integrity of the lysosome are essential for successful fusion to occur. Degradation of the
inner membrane and autophagosome content, including LC3-II, occurs in autolysosomes and relies on
lysosomal hydrolases. Mice lacking Atg5, Atg7, and FIP200, specifically in the central nervous system,
show neurological and behavioral defects, axonal degeneration, and neuronal loss [13]. These findings
highlight the importance of a continuous clearance of cytosolic proteins through basal autophagy,
to prevent the accumulation of abnormal proteins, which may impair neuronal function.
From the middle mid-1960s, nerve crush studies on the rat sciatic nerve have established the
presence of autophagic vesicles within the nervous system [14]. The implication of autophagy in nerve
regeneration is still a matter of investigation. Huang and collaborators (2016) suggested that m-TOR
dependent autophagy induction in Schwann cell biology at the nerve stimulates nerve regeneration [15].
Stimulation of autophagy after spinal cord injury lesion attenuated axonal retraction and promotes
regeneration of descending axons in the long-term by stabilizing microtubules [16]. However, there is
a lack of studies investigating the gap in understanding whether autophagy induction may be relevant
within the motoneurons (MNs), when they shift from an active, electrically transmitting state back to a
silent, growth-competent state that occurs after nerve injury [17]. Thus, it seems likely that induction
of autophagy may be beneficial for motor nerve regeneration, in particular through activation of SIRT1;
herein, we explore these issues.
2. Materials and Methods
2.1. Surgical Procedures
All the experiments involving animals were approved by the Ethics Committee of our institution
and followed the European Community Council Directive 2010/63/EU. Sprague-Dawley rats were kept
under standard conditions of light, temperature, and feeding and at 12 weeks of age, we performed
the surgical procedures. We deeply anesthetized rats with a cocktail of ketamine/xylazine 0.1 mL/100 g
administered intraperitoneally (i.p.) and prepared the animal for surgery. For crush injury, the sciatic
nerve of the right hindlimb was exposed ad mid-high and compressed with fine forceps (3 times of 30”)
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at 90 mm from the third toe [7]. For the cut and suture, we dissected the sciatic nerve as previously
described, transected it at 90 mm from the third toe and immediately repaired it with a fascicular
suture (10-0, Ethicon). Following all surgeries, the wound was closed, disinfected, and the animals
were allowed to recover in a warm environment. For the adeno-associated viral (AAV) injected rats,
surgery was performed three weeks after injection to ensure an optimal gene expression.
The ventral root avulsion (RA) and delayed root reimplantation (RE) were carried out as previously
described [6]. Briefly, we performed laminectomy at T11 vertebra to release the L3–L6 ventral roots
from the meninges, and we detached them separately from the spinal cord with the help of a hook.
In addition, we introduced the four injured roots into a silicone tube, repaired the wounds, and
allowed the animals to recover. Two weeks after RA, we anesthetized the animals and checked by
electrophysiological tests for complete muscle denervation. We localized the silicone tube, dissected
the injured ventral roots, and inserted underneath them the corresponding spinal cord segment. To
ensure maintenance of the reimplanted roots within the spinal cord, we opposed the paraventral
muscles to the spinal cord and close the wounds.
For the hypoglossal model, wild type female C57BL/6 (Charles River Laboratories, Wilmington,
MA, USA) mice, aged 2 months and weighing an average of 24.92 ± 1.66 g (Animal Service, Universitat
Autònoma de Barcelona (UAB)), were maintained under standard conditions of temperature and light
and fed with food and water ad libitum. Surgical procedures were performed under anesthesia with
ketamine (90 mg/kg, intramuscularly [i.m.]) and xylazine (10 mg/kg, i.m.). We carried out axotomy
of the hypoglossal nerve as described elsewhere [18]. Briefly, the right digastric muscle was opened
using blunt-end dissection with a pair of scissors, and the right hypoglossal nerve was exposed. We
transected the nerve with a pair of scissors at the proximal side of the hypoglossal nerve bifurcation and
removed 3 mm from the distal stump. Finally, we separated the nerve stumps to avoid spontaneous
axon regrowth. The muscle was sutured, and the wound closed by planes and disinfected with
povidone-iodine. The animals were allowed to recover in a warm environment.
2.2. Construction, Purification, and Infection with Recombinant Adeno-Associated Vectors
SIRT1 cDNA and ATG5 cDNA were cloned into NheI and XhoI sites between the inverted
terminal repeats (ITRs) of AAV2, under the regulation of the cytomegalovirus (CMV) promoter and
the woodchuck hepatitis virus responsive element (WPRE) [19]. The AAV2/rh10 vector was generated
as previously described [20] by triple transfection of HEK 293-AAV cells (Stratagene) with branched
polyethylenimine (PEI; Sigma) with the plasmid containing the ITRs of AAV2, the AAV helper plasmid
containing Rep2 and Cap for rh10 (kindly provided by JM Wilson, University of Pennsylvania,
Philadelphia, USA) and the pXX6 plasmid containing the helper adenoviral genes [21]. Recombinant
vectors were clarified after benzonase treatment (50 U/mL, Novagen) and polyethylene glycol (PEG
8000, Sigma) precipitation. Vectors were purified using an iodixanol gradient at the Vector Production
Unit of UAB (http://sct.uab.cat/upv), following standard operating procedures. Viral genomes per ml
(vg/ml) were quantified with PicoGreen (Invitrogen, Carlsbad, CA, USA).
We performed intrathecal injection of 4× 1010 viral genomes under ketamine/xylazine-anesthetized
animals using a Hamilton syringe with a 33-gauge needle. For intrathecal injection, the vertebral
column was exposed after muscle dissection at L3–L4 vertebrae, and 10 µL of viral vectors were
slowly injected into the cerebrospinal fluid between vertebras. We introduced the needle and correct
intrathecal placements were confirmed by the animal tail flick. The needle was fixed in the injection
site for 10 s to avoid fluid retraction and the wound was sutured [7].
2.3. Drug Administration
NeuroHeal (NH) is composed of acamprosate calcium (Aca) and Ribavirin (Rib) compounds [7].
Aca, Rib, Ex-527, and nicotinamide (NAM) (Sigma-Aldrich, Saint Louis, MO, USA), and
3-Methyladenine (3MA) (Tocris) for in vitro studies were diluted in sterile H2O or DMSO. Aca,
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Rib, Ex-527, and NAM were added at a final concentration of 1 µM, 55 µM, 10 µm, 5 mM, and 10 µM,
respectively, and were mixed with the culture medium.
In vivo treatment with NH consists of Aca (Merck) and Rib (Normon) pills grounded into a fine
powder and dissolved in drinking water at 2.2 mM and 1 mM, respectively. In some experiments,
NAM was dissolved and added also in the drinking water at 5 mM. We changed the tap water every
3 days and freshly added the drug treatment on a daily basis. DMOG (Tocris), dissolved in DMSO,
was injected daily at 20 mg/kg.
2.4. Electrophysiological Test and Functional Assessment
For electrophysiological evaluation, rats were anesthetized with ketamine/xylazine (100:10 mg/kg
weight, i.p.) at different times post-injury as described before [7]. Briefly, the sciatic nerve was
stimulated by transcutaneous electrodes placed at the sciatic notch by single pulses (20 µs), and the
compound muscle action potential (CMAP) was recorded by placing electrodes on the tibialis anterior
(TA), gastrocnemius, and plantar interosseous muscles. Stimulus intensity was applied gradually
until reaching the supramaximal stimulus, which corresponds to the maximum CMAP amplitude.
The evoked action potentials were displayed on a storage oscilloscope (Synergy Medelec, Viasys
HealthCare) at settings appropriate to measure the amplitude from baseline to peak and the latency
to the onset after every stimulus. For the functional analysis of locomotion, we painted the plantar
surface of rat hind paws with acrylic paint and allowed the rat to walk along a corridor onto a white
paper. Footprints from operated and intact paws were analyzed by measuring the print length (PL),
the distance between the 1st and 5th (TS) or 2nd and 4th (IT) toes with a precision device. The three
parameters were combined to obtain the sciatic functional index (SFI) which quantifies the changes in
walking pattern (0 for uninjured; −100 for maximally impaired gait) [22]. After testing, animals were
allowed to recover in a warm environment.
2.5. Spinal Organotypic Culture (SOCs) on Collagen 3D Matrix
We prepared spinal organotypic cultures as previously described [23]. In summary, we prepared
collagen solution at 3 mg/mL by mixing: rat tail collagen type I (Corning, Wiesbaden, Germany),
phosphate-buffered saline (PBS) (Sigma-Aldrich), sodium bicarbonate at 0.3 mg/mL, and 10X basal
Eagle’s medium (Gibco, Grand Island, USA). We deposited 30 µL-single drops of collagen in 24-well
Petri dishes pre-treated with poly-D-Lysine (Sigma-Aldrich) and kept them in the incubator for 1 h
at 37 ◦C and 5% CO2 to induce collagen gel formation. Thereafter, we extracted lumbar spinal cord
sections from 7 day old Sprague-Dawley rats, placed them in 30% glucose cold Gey’s balanced salt
solution (Sigma-Aldrich) and removed the meninges and nerve roots. Spinal cords were cut into
350 µM–thick slices and were placed onto collagen droplets. After 30 min in the incubator, slices were
covered with 30 µL of the same collagen solution mentioned above; following 30 min at 37 ◦C for
collagen polymerization, we added Neurobasal (Life Technologies) culture medium supplemented
with B27 (Life technologies), glutamine, and penicillin/streptomycin (Sigma-Aldrich).
One day after culture, we removed the media and re-applied the same media combined with the
different treatments: H2O or DMSO as a vehicle, NH, NH + Ex-527, NH+NAM NH+3MA, DMOG,
DMOG+3MA, and 3-MA. We then changed the medium at 3 days post culture. After 4 days of
treatment, we removed the media, post-fixed the spinal cord slices with cold 4% paraformaldehyde
(PFA) solution for 1 h, washed them with Tris-buffered saline (TBS) several times, and incubated
slices with primary antibodies for 48 h at 4 ◦C. For neurite growth analysis the primary antibody was
an anti-mouse RT97 (1:200; Hybridoma Bank, USA). After washing with 0.1% Tween 20 in TBS, we
incubated the spinal cord slices with a donkey-conjugated Alexa 594 anti-mouse antibody (1:200; Life
Technologies) overnight at 4 ◦C, counterstained with DAPI, washed slices and mounted slides with
DPX (Sigma-Aldrich).
We took sequential microphotographs with an Olympus BX51 (Olympus) fluorescence microscope
attached to a DP73 camera (Olympus DP50) and merged images with Adobe Photoshop CS3 (Adobe
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System, USA) to obtain the entire spinal cord slice bodies with their neurites. To analyze neurite
growth and length, whole culture images were analyzed with the help of the Neurite-J plug-in for
ImageJ software [24]. The number of neurites for each intersection from the explant was calculated
and compared between sets of cultures.
2.6. Cell Culture
SH-SY5Y cells were grown in high-glucose Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with 15% fetal bovine serum (Sigma-Aldrich), and a 0.5× solution of
penicillin/streptomycin (Sigma-Aldrich). Cells were kept in a humidified incubator at 37 ◦C under
5% CO2. For the treatments, we coated plastic plates (Thermo) with 10% collagen dissolved in
Milli-Q water at 37 ◦C for 2 h. After removing this solution, we seeded the cells at a density of
2.5 × 105 per cm2. For a differentiated phenotype, cells were grown in Neurobasal medium (Life
Technologies) supplemented with B27 (Life technologies), 1 µM of retinoic acid (Sigma), and a 0.5×
penicillin/streptomycin solution. After 3 days in culture without changing the medium, SH-SY5Y
cells presented with a differentiated-like phenotype characterized by the presence of long neurite
extensions. At this time, we added different drugs to the cells. The drugs, prepared at a ten-fold
higher concentration than the concentration to be tested, were dissolved in DMEM to the desired
concentration and used to replace the medium over cells. We used 1 mM DMOG (Tolcris) and 10µM
3-MA (Merck-Millipore) unless otherwise stated. After 24 h, we fixed the cells with 4% PFA, rinsed
twice with PBS, and stored at −20 ◦C or added blocking buffer containing PBS plus 0.3% (v/v) Triton
X-100 and 10% fetal bovine serum. We incubated with the following primary antibodies: mouse
anti-β-tubulin (1:500, Covance/BioLegend), mouse anti-HIF1α (1:500, Novus Biological), and rabbit
anti-SIRT1 (1:200, Merck-Millipore) in 0.5× blocking buffer in PBS, at 4 ◦C overnight. The following
day, after several washes with PBS plus 0.05% Tween-20, we incubated the cells on coverslips with Cy3-
or Cy2-conjugated secondary antibodies (Jackson Immunoresearch); cells were counterstained with
DAPI and coverslips were mounted with Mowiol. Images were taken under the same exposure times,
sensitivities, and resolutions for each marker analyzed with the aid of a digital camera (Olympus DP50)
attached to a fluorescence microscope (Olympus BX51).
For transfection experiments, we transfected 1× 106 cells with 1µg, shRNAGFP (CSHCTR001-CH1,
Tebu-bio), shRNA HIF1α (HSH008832-32-CH1, Tebu-bio), and SIRT1 using the Amaxa Nucleofector II
TM (Lonza) and the Nucleofactor V kit (Lonza) following the manufacturer’s recommendations.
To analyze neurite growth, we took microphotographs at 20×magnification and culture images
were analyzed with the help of ImageJ software. The growth of neurites was measured manually and
compared between sets of cultures.
2.7. Tissue Processing for Histology
At end-stage, we euthanized the animals after dolethal injection (60 mg/kg i.p.) and transcardially
perfused them with a saline solution of heparin (10 U/mL) followed by 4% paraformaldehyde in 0.1 M
PBS buffer solution. In addition, we harvested L4–L5 spinal cord segments post-fixed them with 4%
PFA for 1 h, and cryopreserved them in 30% sucrose solution. Serial spinal cord sections of 20 µm
(20 series of 10 sections each) were obtained with the aid of a cryotome (Leica, Heidelberg, Germany)
and kept at −20 ◦C until needed.
2.8. Immunohistochemistry and Image Analysis
Sections for each marker from different animals of each group to be analyzed together were
immunolabeled simultaneously and the analysis was performed at the same time. We washed the
spinal cord slices with TBS, blocked them with TBS-Glycine 0.1 mM during 1 h, and with blocking
solution (TBS with 0.3% Triton-X-100 and 10% donkey serum) for 1 h at room temperature (RT). Next, we
incubated with the primary antibodies overnight at 4 ◦C. The primary antibodies used were: rabbit-anti
NAD-dependent deacetylase sirtuin-1 (SIRT1; 1:100, Millipore), rabbit anti-acetyl-Histone H3 (Lys9)
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(Acetyl H3-K9; 1:50, Millipore), rabbit anti-acetyl-p53 (Lys373), anti-growth associated protein-43
(GAP43; 1:50, Millipore), mouse anti-hypoxia inducible factor 1α (Hif-1 α; 1:200 amplified with
streptavidin-biotin, Novus Biologicals), mouse anti-Atg5 (1:1000, Nanotools), and rabbit anti-phospho
ribosomal protein S6 kinase (Thr 389) (p-P70S6K; 1:100, Antibodies Online). We washed with TBS-0.1%
Tween-20 to remove the primary antibody excess and added specific donkey-Cy3 or Alexa 488 secondary
antibodies (1:200; Jackson Immunoresearch) for 1 h and 30 min at RT. We then washed the slices with
TBS-0.3% Triton-X-100 and added the fluorescent green NeuroTracer Nissl Stain (Molecular Probes,
Leiden, Netherlands) and DAPI (Sigma, St Louis, MO, USA) to counterstain. After several washes with
TBS and tris buffer, slices were mounted with Fluoromount-G mounting medium (SouthernBiotech).
We examined with a Confocal Laser Scanning Microscope (Zeiss LSM 700; Zeiss, Jena) the
immunolabeled spinal cords from different animals and experimental groups. Confocal images
were systematically acquired using three separate photomultiplier channels with a 20x objective of
1.4 numerical aperture under the same conditions of exposure time, resolution, and sensibility for
each analyzed marker. Images were separately projected and the signal intensity was analyzed with
the aid of the ImageJ software (National Institutes of Health; available at http://rsb.info.nih.gov/ij/).
The Nissl labeling was used as ROI (Region Of Interest) to enclose the MN cytosolic area, and the
integrated density within the ROI was obtained for at least 15 MNs extracted from three different
sections (separated 100 µm between each other) per animal for each marker [7].
2.9. Western Blotting
For immunoblotting studies, we collected the L4–L5 segment of the spinal cord from each animal
(n = 3/4 per experimental condition) at end-stage and added lysis buffer (50 mM Tris, 2 mM EDTA,
0.5% Triton-X-100, 10 mM Nicotinamide, and a cocktail of protease [Sigma] and phosphatase [Roche]
inhibitors; pH = 6.8). We homogenized lysates on ice with the aid of a pellet pestle (Sigma-Aldrich,
sonicated it with an ultrasonic homogenizer (Model 3000, Biologics Inc) and we centrifuged at 13,000
g during 10 min at 4 ◦C. The supernatant was harvested and quantified with the BCA assay (Pierce
Chemical Co.) according to the manufacturer’s instructions. Equal amounts of proteins from each
animal (10 µg/well) were resolved on SDS-PAGE gels and transferred to a nitrocellulose membrane in a
BioRad cuvette system in standard buffer composition (25 mM Tris, 192 mM glycine, 20% (v/v) methanol,
pH 8.4). We blocked the proteins for 1 h at RT with 5% low fat milk in 0.1% Tween-TBS for 1 h at RT
and incubated them overnight with different primary antibodies: rabbit anti LC3B (1:1000, Abcam),
mouse anti-p62 (1:500, Novus Biologicals) mouse anti-p-ULK1 (1:500, Santa Cruz Biotechnology),
mouse anti-Atg5 (1:1000, Nanotools), rabbit anti-Beclin1 (1:2000, Abcam), and anti-β-actin (Actin;
1:3000; Sigma Aldrich). After several washes, we incubated the membrane for 1 h with an appropriate
secondary antibody conjugated with horseradish peroxidase (1:5000, Vector). The proteins were
visualized using a chemiluminescent method (ECL Clarity kit, Bio-Rad Laboratories, Berkeley, CA,
USA) and the images were captured and quantified with Image Lab Software (Bio-Rad Laboratories).
2.10. Statistical Analysis
Data are presented as the mean ± standard error of the mean (SEM). Results were statistically
analyzed using the GraphPad Prism 5 software (San Diego, CA, USA) by unpaired t-test to compare
two groups, or one or two-way analysis of variance (ANOVA) followed by Bonferroni’s post hoc test
between groups. Statistical significances were taken with a p-value of <0.05.
3. Results
3.1. ATG5 Overexpression Increases Functional Reinnervation and Recovery
In order to ascertain whether autophagy induction was important in motor nerve regeneration,
we aimed to investigate the potential to shift MNs to a growth-competent state by ATG5 overexpression,
previously shown to induce autophagy [25]. For this purpose, a nerve conduction test was performed
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to rats injured with sciatic nerve transection and suture that received previously intrathecal injections
of AAV vectors (AAVrh10) to overexpress either ATG5 (AAVrh10-ATG5) or the non-related protein GFP
(green fluorescence protein) (AAVrh10-GFP), specifically within the spinal MNs [26]. The compound
muscle action potential (CMAP) response of the gastrocnemius (GA), tibialis anterior (TA), and plantar
interosseous muscles recorded at one week after nerve injury demonstrated complete denervation
of the hindlimb muscles. Initial evidence of functional reinnervation of TA, GA, and plantar was
found at around 18, 28, and 38 days post-injury, respectively, in some animals from all groups with
CMAPs of small amplitudes. The amplitudes progressively increased with a similar pattern and
magnitude in both group of animals. However, we detected higher TA and GA recorded amplitudes in
the AAVrh10-ATG5 than in AAVrh10-GFP groups at 48 days (TA) and 60 days post injury (dpi) (TA
and GA) (p < 0.05) (Figure 1A). No differences in functional reinnervation were observed more distally
with still very small amplitudes (<0.05 mV) by 60 dpi for the plantar muscles. Importantly, we found
a significant reduction of the sciatic functional index (SFI) analyzed by walking and tracking of the
animals. This result suggested that the motor performance of hindlimb movements was better in the
AAVrh10-ATG5 than in the AAVrh10-GFP group (Figure 1B).
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Figure 1. ATG5 overexpression ncreases motor axon regen ration. (A) Mean amplitudes (±SEM) values
of compound muscle action potential (CMAP) recordings btained during follow-up post-ax tomy
from tibialis anter or, gastrocnemius, and plant r muscles in animals overexpressing GFP or ATG5
(n = 4–5, ANOVA, post hoc Bonferroni, * p < 0.05 vs. AAV-GFP). (B) Left, r h of the sciatic
functional index (SFI) obtained with the walking track analysis of the sciatic nerve in injured animals
overexpressing ATG5 or GFP (t-test, * p <0.05 vs. AAV-GFP). Right, representative footprints from ipsi-
and contra-lateral paws at 60 days post-injury (dpi). (C) Representative confocal images of infected
motoneurons (MNs) with either AAVrh10-GFP or AAVrh10-ATG5, immunolabeled for ATG5, GAP-43,
and phospho-p70S6K at T-389, counterstained with FluoroNissl Green (left panels) or FluoroNissl
Blue (right panels) and merged images at 60 dpi after nerve axotomy. Scale bar = 50 µm and 25 µm
for ZOOM.
We confirmed that by 60 dpi, ATG5 was still overexpressed within MNs of the AAVrh10-ATG5
group compared to the AAVrh10-GFP group of injured animals (Figure 1C). Furthermore, this was
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accompanied by the presence of abundant GAP43-positive staining within MNs suggesting a persistent
growth-competent state in the former group (Figure 1C). Since we previously had demonstrated
increased autophagy induced by ATG5 overexpression in MNs using this viral vector, we wondered
whether this was dependent on mTOR kinase. To test this, we analyzed the levels of phosphorylated
p70S6K (T-389), a widely mTOR kinase substrate used as a readout of mTOR activity [27,28], and found
no differences between the two groups (Figure 1C). This observation pointed to the induction
of mTOR-independent autophagy to improve functional reinnervation by ATG5 overexpression
within MNs.
Altogether, these results indicate that mTOR-independent autophagy activation is important for
better motor regeneration and functional recovery.
3.2. NeuroHeal Improves Axon Regeneration by SIRT1 Activation
Considering that autophagy can be triggered by AMPK as an mTOR independent mechanism [29],
we investigated whether downstream SIRT1 activation that regulates the formation of autophagic
vacuole may also improve regeneration [30]. We first performed a pharmacologic approach using the
previously described NeuroHeal, as a SIRT1 activator [7,18]. The NeuroHeal-treated group of rats
with cut and suture of the sciatic nerve presented significantly higher CMAP amplitudes compared to
the vehicle-treated group of the GA muscle at 48, and 60 dpi, and of the plantar muscle at end-point
(p < 0.05, Figure 2A). Interestingly, these differences were lost in injured animals treated with NeuroHeal
plus nicotinamide (NAM), which may act as SIRT1 inhibitor (Figure 2A). Using a different model,
3D collagen matrix embedded spinal cord organotypic cultures (SOCs) [23], we assessed facilitation of
neurite outgrowth after NeuroHeal treatment alone or in combination with two well-known inhibitors
of SIRT1 activity, Ex-527, and NAM. NeuroHeal treatment significantly increased the number and
maximum length of neurites propelled out from SOCs within the permissive substrate (Figure 2B).
We verified that the effect stimulated by NeuroHeal could not be attributed to any of its single
components, acamprosate or ribavirin (Figure S1). The concomitant treatment of NeuroHeal with
the SIRT1 inhibitors completely blocked its pro-neuritogenic effect and the maximum length of the
extended neurites. In agreement with this, the level of GAP43, a hallmark of regeneration, was only
increased by NeuroHeal treatment but was downregulated when adding SIRT1 inhibitors (Figure S2).
These results suggest that SIRT1 activation by NeuroHeal facilitates its pro-regenerative effect.
To investigate whether autophagy induction had a role in neurite outgrowth mediated by SIRT1
activation, we treated SOCs with the PI3K inhibitor 3-Methyladenine (3MA) that inhibits autophagy
by blocking autophagosome formation via the inhibition of class III phosphoinositide 3-kinase
(PI3K/hVps34) when used in short periods to inhibit autophagy [31]. PI3K mediates autophagy at both
the initiation and maturation stages of autophagosomes [31]. We observed that the addition of 3MA
on NeuroHeal-treated SOCs blocked its beneficial effects on both neurite outgrowth and elongation
(Figure 2B).
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Figure 2. Pro-regenerative effect of NeuroHeal requires SIRT1 activity and autophagy. (A) Mean
amplitudes (±SEM) values of CMAP recordings obtained during follow-up post-axotomy from
gastrocnemius (GA) and plantar muscles in animals treated with NH, NH+nicotinamide (NAM),
or NAM (n = 5–6, ANOVA, post hoc Bonferroni, * p < 0.05 vs. Injury). (B) Representative
microphotographs of Veh-, NH-, NH+Ex-527-, NH+NAM-, and NH+3MA-treated spinal cord
organotypic cultures (SOCs) embedded in collagen. Graphs show the number of neurites per
intersection and the maximum neurite length in the SOC (n = 8–10, ANOVA, post hoc Bonferroni,
* p < 0.05 vs. Veh, # p < 0.05 vs. NH+Ex-527, $ p < 0.05 vs. NH+NAM, % p < 0.05 vs. NH+3MA). Scale
bar = 250 µm.
3.3. Autophagy Promoted by SIRT1 Overexpression Is Necessary for Nerve Regeneration
We further characterize whether specific SIRT1 overexpression may induce autophagy and increase
functional nerve reinnervation. We generated AAVrh10-SIRT1 particles to drive its expression into spinal
MNs in animals posteriorly subjected to microsurgery for cut and suture of the sciatic nerve. As expected,
SIRT1 expression increased in th cyto ol of spinal MNs in animal injected with AAVrh10-SIRT1
compared to those with AAVrh10-GFP at 7 dpi (Figure 3A). One key molecule in autophagy is
ATG5, which, when conjugated to ATG12, forms part of the com lex that mediat s t e lipi ation of
Microtubule-associated protein 1 light chain 3 (MAP-LC3/Atg8/LC3 II) at the autophagosome [32,33].
We observed that ATG5 was accumulated in damaged MNs when SIRT1 was overexpressed compared
to the AAVrh10-GFP group (Figure 3B). In contrast, the level of the phosphorylated form of p70S6K
(T-389) that depends on mTOR-activity did not differ between the two groups (Figure 3B). We also
analyzed the level of some autophagy markers by immunoblotting. At 7 dpi, we observed a significant
increase in the level of ATG5-ATG12-conjugate and a trend of an increase for the LC3II isoform,
promoted by SIRT1 overexpression compared to the AAV10-GFP group (Figure 3C). No differences
were found in p62 levels, whose accumulation usually indicates autophagy flux blockade. These effects
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were reversed by treatment with NAM in animals from the AAVrh10-SIRT1 group where only p62
levels had a tendency to increase (Figure 3C).
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FluoroNissl (green) in MNs from the AAVrh10-GFP or AAVrh10-SIRT1 after axotomy at 60 dpi Scale bar
= 20 µm. (B) Representative confocal images of MNs stained with ATG5 and p-p70S6K at T-389 with
FluoroNissl green from the different groups and associated bar graphs of the mean (±SEM) intensity for
each marker inside the cytoplasm of injured MNs at 7 dpi (n = 4 animals per group, t-test, * p < 0.05 vs.
AAV-GFP) Scale bar = 20 µm. (C) Western blot and corresponding bar graphs of the quantification of
different proteins related to autophagy (ATG5, LC3-II, and p62) in the spinal cord from axotomy-injured
animals injected with AAVrh10-GFP or AAVrh10-SIRT1 with or without oral nicotinamide (NAM).
(n = 4, ANOVA, post hoc Bonferroni, * p < 0.05 vs. AAV-GFP). (D) Mean amplitudes (±SEM) values of
CMAP recordings obtained during follow-up post-axotomy from the gastrocnemius (GA) and plantar
muscles in animals overexpressing GFP or SIRT1 (n = 4–6, ANOVA, post hoc Bonferroni, *p < 0.05 vs.
AAV-GFP (E) Up, Confocal images of MNs immunolabeled for SIRT1 in red and counterstained with
FluoroNissl (green) and DAPI (blue) from MNs of Contra, crush, and NH-treated animals at 35 dpi.
Scale bar = 50 µm. Down, Histograms of the mean of the SIRT1 immunofluorescence intensity inside
the cytoplasm of injured MNs (n = 3 animals per group, ANOVA, post hoc Bonferroni, * p < 0.05 vs.
contra and # p < 0.05 vs. Crush). (F) Top, Confocal microphotographs and graphs showing levels of
SIRT1 (red) co-labeled with FluoroNissl (green) from contralateral site (Contra RE), sham (Sham RE),
and after peripheral nerve root avulsion with reimplant (RE). Scale bar = 25 µm. Bottom, Graph of the
means of the immunofluorescence intensity inside MNs or inside the nuclei of MNs (n = 3–4 per group,
ANOVA, post hoc Bonferroni, * p < 0.05 vs. Contra RE, # p < 0.05 vs. Sham RE).
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Extended follow up of the animals allowed for CMAP amplitudes recording. We found that
animals from the AAVrh10-SIRT1 group presented significant higher amplitudes than those in the
AAVrh10-GFP group, in both GA and plantar muscles by 60 dpi (Figure 3D). Altogether, these
results suggest that SIRT1 overexpression and activation have a relevant role in promoting motor
nerve regeneration.
3.4. SIRT1 Is in the Cytosol of Spinal MNs in Growth-Competent State
To investigate further the underlying mechanisms downstream SIRT1-mediated autophagy
important for nerve growth, we considered the observation that SIRT1 was mainly located at the
cytosol within MNs in the AAVrh10-SIRT1 group, while its normally reported location is in the nucleus
of neurons. This was not a single event since we also found SIRT1 within the cytosol in other models.
For instance, after sciatic nerve crush, MNs switch from a transmitting mode to a growth-competent
state as a pro-regenerative mode [34]. We observed an increase in cytosolic SIRT1 within MNs, already
after nerve crush and when the injured animals were treated with NeuroHeal, which also improved
regeneration in this model, as previously reported [18] (Figure 3E). In another model of ventral root
avulsion and delayed reconnection [6], we had also observed that SIRT1 was translocated from the
nucleus to the cytosol only when reconnection was allowed (Figure 3F). These observations suggested
that SIRT1 activity should be enhanced in the cytosol to allow nerve regeneration.
3.5. SIRT1/HIF1α-Autophagy Axis Activation Enhances Neurite Outgrowth
Regarding the presence of SIRT1 in the cytosol, we explored changes in one of its cytosolic
substrates, the hypoxia-inducible factor 1α (HIF-1 α), because of its reported relationship with
regeneration in Caenorhabditis elegans and sensory neurons [35–37]. We observed that Hif1α was
accumulated in AAVrh10-SIRT1 compared to AAVrh10-GFP group of injured animals by nerve cut and
suture (Figure 4A). Similarly, injured animals treated with NeuroHeal presented higher levels of Hif1α
than vehicle-treated animals in both the cut/suture model (Figure 4B) and the crush model (Figure
S3). Likewise, in SOC explants, the addition of NeuroHeal increased the levels of Hif1α, which was
blocked by the concomitant addition of SIRT1 inhibitors EX527 or NAM (Figure 4C).
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Figure 4. SIRT1 activity stabilizes HIF1α in motoneurons (A) Representative confocal images of MNs
stained with HIF1-α FluoroNissl green from the different groups and associated bar graphs of the
mean (±SEM) intensity for each marker inside the cytoplasm of injured MNs from AAVrh10-GFP or
AAVrh10-SIRT1 animals. (n = 4 animals per group, t-test, * p < 0.05 vs. AAV-GFP) Scale bar = 20 µm.
(B) Representative confocal images of Hif-1α (red) counterstained with FluoroNissl (green) in MNs
from the different groups at 60 dpi. Scale bar = 20 µm Bottom, a bar graph of the mean (±SEM) intensity
for Hif1-1α inside the cytoplasm of injured MNs at 60 dpi (n = 3–4, ANOVA, post hoc Bonferroni).
Scale bar = 20 µm (C) Left, Representative confocal images of HIF-1α (green) counterstained with
RT-97 (red) of MNs from SOCs of different conditions. Scale bar = 20 µm. Right, Bar graphs of the
mean (±SEM) intensity for each marker inside the cytoplasm of MNs (n = 10–18, ANOVA, post hoc
Bonferroni, * p < 0.05 vs. Veh, $ p < 0.05 vs. NH).
Considering the studies available in the literature that correlate either the cytosolic activity of
SIRT1 or HIF-1 α with autophagy [38–41], we aimed to further explore this pathway in the regenerative
context. To investigate whether Hif1α-induced autophagy has pro-regenerative effects, we treated
SOCs with DMOG, an inhibitor of the prolyl hydroxylases, enzymes that drive Hif1α degradation
by hydroxylation [42]. We had previous evidence that HIF1α was stabilized after DMOG treatment
in a model of hypoglossal nerve injury (Figure S4). We observed that DMOG treatment of SOCs
augmented pUlk1 (Ser555) levels, a marker of autophagy induction, although no differences were
observed in LC3II or p62 levels (Figure 5A). The addition of 3MA impeded pUlk1 increase by DMOG as
expected, but increased LC3II and p62 levels suggesting autophagy flux blockage (Figure 5A). We also
analyzed neurite outgrowth and observed that SOCs treated with DMOG significantly boosted neurite
outgrowth and length, which was abolished by the addition of 3MA (Figure 5B). These results suggest
that Hif1α accumulation has a neuritogenic effect that depends on autophagy.
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Figure 5. Hif-1α-dependent autophagy increases motor axon growth. (A) Western blots and histogram
showing the analysis of pUlk1 (Ser555), ATG5-ATG12 LC3II, and p62 protein level from SOCs after 2
days of treatment with vehicle (Veh), DMOG, 3-MA, or DMOG+3-MA (n = 3–4, ANOVA, post hoc
Bonferroni * p < 0.05 vs. DMOG, # p < 0.05 vs. Veh). (B) Representative microphotographs of Veh-,
DMOG-, and DMOG+3MA-treated SOCs embedded in collagen. Graphs show the number of neurites
per intersection and the maximum neurite length in the SOCs (n = 8–9, ANOVA, post hoc Bonferroni,
* p < 0.05 vs. Veh, # p < 0.05 vs. DMOG+3MA). Scale bar = 250 µm.
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To confirm whether the SIRT1 pro-regenerative effect was mediated by Hif1α stabilization, we used
another in vitro model based on the neurite extension observed in the human cell line SH-SY5Y. We
observed that DMOG treatment significantly increased the average neurite length extended out from
these cells as observed in SOCs and analyzed with β-III-tubulin immunostaining (Figure 6A). Similarly
to what observed in SOCs, the addition of 3MA to the DMOG-treated cells prevented these effects
(Figure 6A). NeuroHeal treatment also increased neurite length, an effect that was abolished by SIRT1
inhibition with EX527 or autophagy inhibition with 3MA (Figure 6B). Furthermore, we nucleofected
the cells to overexpress SIRT1 and/or silence Hif1α using shRNA (Figure S5). We observed that SIRT1
overexpression significantly increased average neurite length, which was abolished by Hif1α shRNA,
indicating that Hif1α was crucial in promoting the SIRT1-dependent axonal regeneration. (Figure 6C).Cells 2019, 8, x FOR PEER REVIEW 14 of 20 
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cells in transfected cells with eGFP, shRNA/HIF1, SIRT-1 or the combination of shRNA/HIF+ SIRT-1.
(n = 3–4, ANOVA, post hoc Bonferroni * p < 0.05 vs. eGFP, # p < 0.05 vs. SIRT1). Scale bar = 100 µm.
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4. Discussion
In the present work, we aimed to explore whether autophagy induction was an important issue in
favor of motor nerve regeneration after PNI. We found that specific induction of autophagy by ATG5
or SIRT1 overexpression improved motor functional reinnervation. Interestingly, most of the SIRT1
overexpression was located in the cytosol of growth-competent state MNs narrowing the possible
downstream substrates. Among these, HIF1α stabilization and downstream activation of autophagy
was found necessary to promote neurite outgrowth in organotypic spinal cord cultures and human cells.
We have found that activation of autophagy, by either ATG5 or SIRT1 overexpression, improves
motor functional reinnervation in a rat model of nerve transection and repair. We observed an increase
in the ATG5-ATG12 complex in the spinal cord from SIRT1-overexpressing animals suggesting that the
origin of autophagy was in the MN soma as a driving force of motor nerve regeneration. A lesion
triggers a drastic response in soma and axon, including chromatolysis, axonal membrane sealing,
growth cone Rohon–Beard (RB) formation, and Wallerian degeneration. The growth cone initiation and
axon regeneration require extensive remodeling of the cytoplasmic compartment and axon structures,
which involve the synthesis and degradation of local proteins. Autophagy is one of the major pathways
for bulk cytosolic degradation and efficient turnover under stress. Our study is in agreement with He
and collaborators (2016), who reported induced autophagy promotes central nervous system axonal
regeneration after injury by increasing microtubule (MT) stability [16]. In addition, we previously
observed that ATG5 overexpression in MNs induced autophagy but also corrected cytoskeletal
alterations [25]. The fact that plantar CMAP amplitudes are significantly greater within 60 days when
overexpressing SIRT1 than when overexpressing ATG5, suggests that other pathways triggered by
SIRT1 might be synergistically contributing to a better recovery.
SIRT1 has been reported to play a central role in axonogenesis and optic nerve regeneration [43–47].
In sensory axonal regeneration, SIRT1 activation slows its degeneration from dorsal root ganglia [48].
Herein, we show that SIRT1 activation or overexpression improves motor nerve regeneration after
damage. Particular interesting is the fact that SIRT1’s main cytosolic location correlates with a
growth-competent state of the MN in several animal models of PNI. Although SIRT1 is predominantly
a nuclear protein, a similar cytosolic location was found in neonatal and adult MNs after injury and
after NeuroHeal treatment [7,18]. Other authors have reported SIRT1 in the cytosol related to the
process of neuronal differentiation [49–51]. We argued that this might be related to the availability
of nicotinamide adenine dinucleotide (NAD+), necessary to sustain SIRT1 deacetylase enzymatic
activity in specific organelles [52]. Local NAD+ production may be strictly modulated by recruitment
of NAD+-biosynthetic enzymes to sites of NAD+-consuming reactions [53]. NAD+ synthesis is
independently regulated in the nucleus and the cytosol, and the cytoplasmic NAD+ pool is maintained
primarily by the NAD+-synthesizing enzyme nicotinamide mononucleotide adenylyltransferase
(NMNAT). Synthesis and maintenance of high NAD+ concentrations have been considered crucial to
axon integrity [54] and SIRT1 is an effector of the axonal protection mediated by increased NMNAT1
activity, whose location might be nuclear or cytosolic. However, it was recently shown that the activity
of NMNAT1 was both necessary and sufficient to prevent axonal degeneration only when translocated
to cytoplasmic compartment [55,56]. The treatment with NeuroHeal might produce abundance of
cytosolic NAD+ since it inhibits IMPDH, a protein largely cytosolic that catalyzes the NAD+-dependent
oxidation of IMP to xanthosine monophosphate [18,57]. Hence, particular cytosolic overexpression of
SIRT1 might be a key factor in promoting nerve regeneration and deserves further studies. From the
therapeutic point and a view towards precision medicine, these observations highlight that it is not
only important to activate or inhibit a specific target, like SIRT1, but also its activity within a particular
subcellular compartment.
In this study, we attempted to unravel SIRT1 downstream signaling involved in nerve regeneration
by analyzing Hif1α, one of its cytosolic substrates, since SIRT1 deacetylates and stabilizes it in
this compartment [58]. Previous studies demonstrated Hif1α was implicated in neuritogenesis in
C. elegans and in mammalian sensory nerve regeneration [36,37,59]. Herein, we confirm Hif1α’s
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important role in neuritogenesis within the SIRT1/Hif1α axis. The question that remained is
how? HIF-1 is a transcriptional mediator of the cellular response to hypoxia, a form of cellular
stress. HIF-1 is a heterodimeric transcription factor consisting of two subunits, HIF-1α and
HIF-1β [60,61]. One possibility examined in the present work considered that HIF1α induced
downstream mTOR-independent autophagy as it has been previously reported [62]. This was
interesting since previous work pointed to local autophagy having an important role in preventing
axonal degeneration or promoting axonal growth. For instance, a recent study showed that Ulk
induces axonal guidance [63] or, after spinal cord injury, the autophagy induction avoids the retraction
of central nervous system axons and enhances their regrowth leading to an increased recovery of
motor function [16]. Although it is known that SIRT1 may drive directly autophagy by inhibiting
mTORC1 and FOXO, and activating key regulatory proteins, such as ATG5, ATG7, and LC3 [52], we
have demonstrated herein that HIF1a is necessary for SIRT1-mediated neuritogenesis. Interestingly,
there are other non-genetic activities for HIF1a in the cytosol that might be relevant to autophagy and
axon regeneration. Cytosolic HIF1a might bind the chaperone Hsp90 [64] and Dicer [65]. It is known
that HIF1a prevents Hsp90 translocation to the nucleus although it is unknown the repercussion on
its necessity for proper neuronal polarization and axon elongation [66]. Another relevant partner is
Dicer, which mediates ubiquitination and autophagic proteolysis and might bridge HIF1α to p62 [65].
In conclusion, several routes are now being explored to provide further details about the components
involved in autophagy-pro-regenerative capability.
Study Limitations and Future Research
The first limitation of this study was that autophagy was analyzed in a particular fixed time-window.
Autophagy flux is a dynamic process and, thus, it would be interesting to unravel the implication of
our pharmacological and genetic modifications in the flow and the molecules and processes involved.
However, due to the largely different experimental groups, we had to focus on a specific time-point
post-injury. Another limitation was that we only analyzed motor axon regeneration, not considering
the effects of NeuroHeal in sensory neurons. We are now initiating these studies in our lab. Indeed,
the work presented here has opened new research lines. We are currently determining the analgesic
effects of NeuroHeal after PNI to reduce neuropathic pain, based on recent articles suggesting that
autophagy is involved in nociception [67,68]. Moreover, a recent article demonstrates that autophagy
induction promotes recovery after spinal cord injury by clearance of an axonal-growth inhibitory
protein [16]. Therefore, SIRT1/Hif1α-mediated autophagy might enhance functional recovery after
spinal cord injury. All these novel research topics will be explored in the near future.
5. Conclusions
In summary, we demonstrate that SIRT1 activation is important for axonal regeneration and
that Hif1a and downstream autophagy mediates this action; thus, our work has identified a new
endogenous mediator of axon regeneration in MNs. Altogether, the knowledge advanced from the
present study opens avenues for therapeutic precise options for nerve repair after PNI.
6. Patents
NeuroHeal is currently under patent review.
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